Companies routinely publish their clinical research, collaborate with academic researchers, and share clinical trial information on public web sites at the time of patient recruitment, after new drug approval, and when investigational research programs have been discontinued. Biopharmaceutical companies will apply these Principles for Responsible Clinical Trial Data Sharing as a common baseline on a voluntary basis, and we encourage all medical researchers, including those in academia and in the government, to promote medical and scientific advancement by adopting and implementing the following commitments.